Tue.Apr 18, 2023

article thumbnail

FDA Amends Moderna, Pfizer EUAs to Simplify Use of Bivalent COVID-19 Vaccines

Drug Topics

Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.

Vaccines 187
article thumbnail

FDA Approves Expanded Indication for Atogepant for Adults With Chronic Migraine

Pharmacy Times

Atogepant (Qulipta; AbbVie) is the first and only oral calcitonin gene-related peptide receptor antagonist to gain FDA approval for the prevention of episodic and chronic migraine.

FDA 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Define Ventures raises $460M to invest in early-stage digital health startups

Fierce Healthcare

Define Ventures raises $460M to invest in early-stage digital health startups hlandi Tue, 04/18/2023 - 09:23

138
138
article thumbnail

When Using Social Media, Always Consider Professionalism First

Pharmacy Times

Social media can be an excellent tool to provide education and build your own brand, but professionalism and appropriateness are paramount.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

In a town plagued by an environmental crisis, a local abortion debate consumes public attention

STAT

BRISTOL, Tenn. — Zoe Poplin cupped her hands around her 17-month-old’s head, as if her palms over his ears could protect him. “I’m worried about him,” she said. She stroked baby Ezra’s back. “Because when they’re little, you know, their little cells are splitting real fast, and he’s growing and all it takes is one misreading, and he could end up with childhood cancer.

article thumbnail

Monotherapy Pembrolizumab Demonstrates Historic Response for Rare Skin Cancer

Pharmacy Times

The treatment from Keytruda and Merck shows a clinical response of 89% for individuals with unresectable metastatic desmoplastic melanoma.

118
118

More Trending

article thumbnail

Non-biological Factors, SDOH Play Key Role in Women’s CVD Risk Assessment

Pharmacy Times

A new scientific statement from the American Heart Association notes that the process falls short for those who are not white.

123
123
article thumbnail

Pharmacy orgs laud Biden administration for extending PREP Act pharmacy access

Drug Store News

Of particular importance is the December 2024 extension providing pharmacy clinicians the ability to provide COVID-19 vaccinations, tests and flu shots.

Vaccines 111
article thumbnail

Full-Fat Yogurt Helps Lower Fasting Glucose Levels for Those With Prediabetes

Pharmacy Times

Findings show that study participants experienced improvements in both blood sugar control and the lipid profile.

123
123
article thumbnail

Opinion: What the recent failures of Mindstrong and Pear tell us about the future of digital mental health

STAT

Over the past five years, digital mental health has risen from a niche topic to a global health priority. Patients, researchers, regulators, and investors alike are thrilled by the potential of ubiquitous mobile technology like smartphones to help diagnose problems, monitor health, and even deliver evidence-based therapies. Two companies that came to embody this potential were Mindstrong for smartphone monitoring of mental health and Pear Therapeutics for FDA-approved apps and digital interventi

FDA 95
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pharmacy Focuses on Personalized Care

Pharmacy Times

The Apothecary Shoppe in Utah knows patients by name, garners new business via word of mouth.

132
132
article thumbnail

FDA approves IntelGenx’s Rizafilm for acute migraine treatment

Pharmaceutical Technology

IntelGenx Corp announced that the US Food and Drug Administration (FDA) has approved the company’s Rizafilm VersaFilm new drug application (NDA) for the treatment of acute migraine. The approval was based on successful results from a bioequivalence study comparing Rizafilm to Merck and Co’s Maxalt-MTL and the European reference Maxalt-Lingua. Rizaport and Maxalt are different formulations of Rizatriptan benzoate.

FDA 98
article thumbnail

FDA says older adults and the immunocompromised may get a spring booster dose of Covid vaccine

STAT

People ages 65 and older and those who are immunocompromised will be allowed to receive an additional dose of Covid-19 vaccine this spring if they wish, the Food and Drug Administration announced Tuesday. In authorizing another dose for people in these demographics, the agency is following in the footsteps of Canada and the United Kingdom, which earlier announced that older adults, adults who live in care facilities, and people who are immunocompromised would have access to an additional booster

article thumbnail

Liquid Biopsy-based Multicancer Test May Detect Early-stage Disease, Low DNA-Shedding Cancers

Pharmacy Times

Multicancer early detection test could detect cancer with an AUC of 0.94 for all cancer types and stages.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Opinion: Rural hospitals are closing labor and delivery services. Babies’ lives are in jeopardy

STAT

A hospital in Idaho recently announced it will shutter its labor and delivery services due to doctors’ unwillingness to practice medicine in the face of the state’s restrictive and punitive laws surrounding reproductive health care. This comes on the heels of a hospital in rural Washington state closing its labor and delivery services due to concerns over the cost of these services.

article thumbnail

Durvalumab May Increase Survival in Patients with Resectable Non-small Cell Lung Cancer

Pharmacy Times

Durvalumab lowered the risk of death by 32% in patients with non-small cell lung cancer compared to chemotherapy alone.

article thumbnail

AWS notches partnerships with 3M, Philips as it strengthens foothold in healthcare cloud, AI

Fierce Healthcare

AWS notches partnerships with 3M, Philips as it strengthens foothold in healthcare cloud, AI hlandi Tue, 04/18/2023 - 15:01

115
115
article thumbnail

A CMO’s quest to tackle infectious diseases leads him to an eye condition that’s often overlooked

PharmaVoice

How an “international” childhood sent Dr. José Trevejo, Tarsus’s chief medical officer, on a mission to fight infectious diseases.

98
article thumbnail

CVS Health releases Health Trends: Future of Healthy Aging report

Drug Store News

The report found that older adults seeking health care have more confidence in their pharmacist (55%) and primary care provider (65%) than any other age group.

96
article thumbnail

Report: Hospitals, payers making strides on price transparency compliance

Fierce Healthcare

Report: Hospitals, payers making strides on price transparency compliance dmuoio Tue, 04/18/2023 - 09:49

Hospitals 116
article thumbnail

Giant Food partners with Baltimore government to benefit SNAP, EBT eligible residents

Drug Store News

Residents in Baltimore City with SNAP and EBT benefits can save on produce accessible through Giant Pickup and Giant Delivers orders.

98
article thumbnail

HIMSS23: Google proceeds with caution in piloting its LLM in healthcare

Fierce Healthcare

HIMSS23: Google proceeds with caution in piloting its LLM in healthcare aburky Tue, 04/18/2023 - 17:52

115
115
article thumbnail

Revolution Beauty broadens distribution to Walmart

Drug Store News

Relove by Revolution will offer eyebrow and foundation collections and trend-driven products priced at $5 or less, the company said.

98
article thumbnail

No Surprises Act largely successful in protecting consumers though gaps remain, stakeholders say

Fierce Healthcare

No Surprises Act largely successful in protecting consumers though gaps remain, stakeholders say dmuoio Tue, 04/18/2023 - 15:18

98
article thumbnail

NSAIDs reign, naturals rise

Drug Store News

Traditional OTC pain relievers remain popular, but topical and natural solutions are gaining traction.

111
111
article thumbnail

Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A

Fierce Pharma

Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A aarmstrong Tue, 04/18/2023 - 09:47

98
article thumbnail

Blue Bunny preps for summer with new frozen treats

Drug Store News

Blue Bunny’s new launches include Mini Bars, Soft Scoopables and two new flavors additions to its Twist Cones line.

104
104
article thumbnail

AbbVie's Qulipta gains edge on Pfizer's Nurtec with FDA approval to prevent chronic migraines

Fierce Pharma

AbbVie's Qulipta gains edge on Pfizer's Nurtec with FDA approval to prevent chronic migraines zbecker Tue, 04/18/2023 - 11:09

FDA 96
article thumbnail

Giant Food partners with Baltimore government to benefit SNAP, EBT eligible residents

Drug Store News

Residents in Baltimore City with SNAP and EBT benefits can save on produce accessible through Giant Pickup and Giant Delivers orders.

96
article thumbnail

GSK to acquire BELLUS for £1.6 billion

European Pharmaceutical Review

GSK has agreed to acquire late-stage biopharma BELLUS Health, for a total of £1.6 billion. The proposed acquisition will give GSK access to camlipixant, a highly selective P2X3 antagonist for first-line treatment of adults with refractory chronic cough (RCC). “This proposed acquisition builds on our expertise in respiratory therapies,” commented Luke Miels, Chief Commercial Officer at GSK.

82
article thumbnail

Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi

Fierce Pharma

Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi esagonowsky Tue, 04/18/2023 - 08:25

96
article thumbnail

Latest Outcomes in Adult Patients With Ph+ ALL Using TKIs With Modified USC Regimen

Pharmacy Times

Substantial strides have been made in the management of Ph+ ALL.

118
118
article thumbnail

Three former Livongo executives launch a new health care provider focused on rural communities

Drug Store News

The venture is focused on improving access to affordable primary and specialty care in rural communities.

98
article thumbnail

Embracing Personalization in Biopharma Patient Support Programs

Fierce Pharma

Embracing Personalization in Biopharma Patient Support Programs mteefey Tue, 04/18/2023 - 14:48

98